Dimitra Kritikou
Overview
Explore the profile of Dimitra Kritikou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aggelaki E, Giannakopoulos A, Georgiopoulou P, Chasapi S, Efthymiadou A, Kritikou D, et al.
Metabolomics
. 2025 Feb;
21(1):25.
PMID: 39920379
Introduction: The diagnosis of Growth Hormone Deficiency (GHD) during childhood has been the subject of much controversy over the last few years. Aiming to accurate medical treatment, there is a...
2.
Giannakopoulos A, Efthymiadou A, Kritikou D, Chrysis D
Heliyon
. 2024 Mar;
10(6):e27565.
PMID: 38509997
Background And Aims: Osteoprotegerin (OPG) is a tumor necrosis factor receptor superfamily member which increases in chronic inflammation and is associated with altered bone turnover and cardiovascular complications. In this...
3.
Giannakopoulos A, Kritikou D, Chrysis D
J Pediatr Endocrinol Metab
. 2024 Mar;
37(5):441-444.
PMID: 38462927
Objectives: Arginine-stimulated serum copeptin has been proposed as a new method to diagnose arginine vasopressin (AVP) deficiency in children and adolescents. Herein we investigated the secretagogic potential of clonidine or...
4.
Matzarapi K, Giannakopoulos A, Chasapi S, Kritikou D, Efthymiadou A, Chrysis D, et al.
Metabolomics
. 2022 Oct;
18(10):78.
PMID: 36239863
Introduction: Premature adrenarche (PA) for long time was considered a benign condition but later has been connected to various diseases in childhood and adulthood which remains controversial. Objective: To investigate...
5.
Oikonomou N, Fouzas S, Kritikou D, Dimitriou G, Chrysis D, Karatza A
Pediatr Res
. 2022 Oct;
93(7):1955-1958.
PMID: 36195627
Background: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a protein with anti-atherogenic and vasoprotective effects that has never been studied in newborns exposed to preeclampsia. Our aim was to examine...
6.
Kolyva S, Triga M, Kritikou D, Chrysis D
Eur J Pediatr
. 2021 May;
180(11):3273-3278.
PMID: 33973070
Zonulin so far is the only known endogenous modulator of intercellular tight junctions which regulate the intestinal permeability. Breastfeeding is considered to enhance the integrity of the gastrointestinal tract; however,...
7.
Giannakopoulos A, Katsantoni E, Kritikou D, Chrysis D
Acta Paediatr
. 2020 Apr;
109(12):2770-2774.
PMID: 32259306
Aim: In this study, we investigated the osteoprotegerin (OPG) and soluble receptor activator of nuclear factor-kappa Β ligand (sRANKL) serum levels in association with thyroid function in children with subclinical...
8.
Oikonomou N, Papadopoulou C, Fouzas S, Kritikou D, Chrysis D, Sinopidis X, et al.
Early Hum Dev
. 2019 Jun;
135:1-5.
PMID: 31176082
Background: Pre-eclampsia is a known risk factor for long-term cardiovascular complications. Osteoprotegerin (OPG) and the receptor activator of nuclear factor κB ligand (RANKL) have been implicated in the pathogenesis of...
9.
Efthymiadou A, Bogiatzidou M, Kritikou D, Chrysis D
J Pediatr
. 2018 Dec;
205:190-194.
PMID: 30529136
Objectives: To assess whether the serum levels of anti-Müllerian hormone (AMH) are increased in girls with premature adrenarche because they are at a higher risk of developing polycystic ovary syndrome...
10.
Chrysis D, Efthymiadou A, Mermigka A, Kritikou D, Spiliotis B
Pediatr Diabetes
. 2016 Mar;
18(4):277-282.
PMID: 27028343
Introduction: Patients with type I diabetes mellitus (T1DM) have increased incidence of atherosclerosis and cardiovascular disease. Although these complications are unusual in children with T1DM, prevention, and early intervention could...